ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $33.2M invested in ADMA Biologics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
37.01% less ownership
Funds ownership: 71.59% → 34.58% (-37%)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$185K | |
| 2 | +$79K | |
| 3 | +$42K | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$9.07K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.31K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$74K | |
| 3 | -$46.8K | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$40.8K |
| 5 |
SIM
Spark Investment Management
New York
|
-$29.5K |